Sarepta: FDA finds ‘no significant safety issues of concern’ with DMD gene therapy
Sarepta Therapeutics would seem to be edging closer to accelerated FDA approval of its gene therapy for Duchenne muscular dystrophy (DMD).
Archives for March 6, 2023
Moderna chooses Oxford for UK research and manufacturing mRNA hub
Moderna’s UK Innovation and Technology Centre (MITC) will be located at the Harwell Campus in Oxford, and is expected to open in 2025.
Samsung Bio secures drug substance manufacturing deal with Pfizer
Samsung Bio is collaborating with Pfizer, the first time the two entities have teamed up.
Is GMP grade good enough? What mRNA manufacturers need to know when buying raw materials
Paid for and in partnership with Thermo Fisher Scientific - Biosciences
Starting with the end in mind when choosing mRNA raw materials help mitigate costly risks. Seeking quality attributes that go beyond GMP grade is key.